Cargando…
Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225296/ https://www.ncbi.nlm.nih.gov/pubmed/34175482 http://dx.doi.org/10.1016/j.ijid.2021.06.048 |
| _version_ | 1783712061093576704 |
|---|---|
| author | Shukla, Dr. Ajay Kumar Misra, Dr. Saurav |
| author_facet | Shukla, Dr. Ajay Kumar Misra, Dr. Saurav |
| author_sort | Shukla, Dr. Ajay Kumar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8225296 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82252962021-06-25 Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible? Shukla, Dr. Ajay Kumar Misra, Dr. Saurav Int J Infect Dis Letter to the Editor The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-08 2021-06-24 /pmc/articles/PMC8225296/ /pubmed/34175482 http://dx.doi.org/10.1016/j.ijid.2021.06.048 Text en © 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Shukla, Dr. Ajay Kumar Misra, Dr. Saurav Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible? |
| title | Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible? |
| title_full | Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible? |
| title_fullStr | Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible? |
| title_full_unstemmed | Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible? |
| title_short | Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible? |
| title_sort | antiviral effects of ivermectin in covid-19- clinically plausible? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225296/ https://www.ncbi.nlm.nih.gov/pubmed/34175482 http://dx.doi.org/10.1016/j.ijid.2021.06.048 |
| work_keys_str_mv | AT shukladrajaykumar antiviraleffectsofivermectinincovid19clinicallyplausible AT misradrsaurav antiviraleffectsofivermectinincovid19clinicallyplausible |